Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director
CC transcript

BIOCRYST PHARMACEUTICALS INC (BCRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/02/2023 4 MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 680 shares @ $8.27, valued at $5.6k
06/02/2023 4 LEVIN ALAN G (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 1,360 shares @ $8.27, valued at $11.2k
06/02/2023 4 HEGGIE THERESA (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 680 shares @ $8.27, valued at $5.6k
04/05/2023 4 Thackray Helen M. (Chief R&D Officer) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Sold 7,000 shares @ $8.29, valued at $58k
03/23/2023 4 Stonehouse Jon P (President & CEO) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Exercised 31,055 options to buy @ $3.22, valued at $100k
03/02/2023 4 MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 635 shares @ $8.85, valued at $5.6k
03/02/2023 4 INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 2,259 shares @ $8.85, valued at $20k
03/02/2023 4 HEGGIE THERESA (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 635 shares @ $8.85, valued at $5.6k
03/02/2023 4 LEVIN ALAN G (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 1,271 shares @ $8.85, valued at $11.2k
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/19/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 421 shares @ $13.36, valued at $5.6k
12/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/02/2022 4 INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 1,497 shares @ $13.36, valued at $20k
11/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/02/2022 4 MILANO VINCENT (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 404 shares @ $13.9, valued at $5.6k
09/02/2022 4 LEVIN ALAN G (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 809 shares @ $13.9, valued at $11.2k
09/02/2022 4 INGRAM ROBERT ALEXANDER (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 1,438 shares @ $13.9, valued at $20k
09/02/2022 4 HEGGIE THERESA (Director) has filed a Form 4 on BIOCRYST PHARMACEUTICALS INC
Txns: Granted 404 shares @ $13.9, valued at $5.6k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy